The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Fecal calprotectin in predicting relapse of inflammatory bowel diseases: A meta-analysis of prospective studies
Abstract
BACKGROUND: Fecal calprotectin (FC) is a relatively new marker of intestinal inflammation. Recently, many studies have extended its role in predicting relapse of quiescent inflammatory bowel disease (IBD), but the reported results have been inconsistent. We aimed to perform a meta-analysis of the predictive capacity of FC in IBD relapse. METHODS: We systematically searched the Medline, Web of Science, Cochrane Library, and EMBASE databases for prospective studies that used FC concentrations at remission in predicting relapse of Crohn's disease (CD) and ulcerative colitis (UC). Pooled sensitivity, specificity, and other diagnostic indices were evaluated. RESULTS: A total of 672 IBD patients (318 UC and 354 CD) from six different studies were analyzed. The pooled sensitivity and specificity of FC to predict relapse of quiescent IBD was 78% (95% confidence interval [CI]: 72-83) and 73% (95% CI: 68-77), respectively. The area under the summary receiver-operating characteristic (sROC) curve was 0.83 and the diagnostic odds ratio was 10.31 (95% CI: 5.05-21.06). The capacity of FC to predict relapse was comparable between UC and CD. In CD patients the predictive value of FC in isolated small bowel CD was not assessed due to insufficiency of available data. Compared with all enrolled CD patients, FC appeared to be more accurate in ileocolonic and colonic CD. CONCLUSIONS: As a simple and noninvasive marker, FC is useful to predict relapse in quiescent IBD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Van Assche, G., Dignass, A., Panes, J., Beaugerie, L., Karagiannis, J., Allez, M., Ochsenkühn, T., Orchard, T., Rogler, G., Louis, E., et al. (2010) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2009.12.003 · Cited by 1,453
Systematic reviews of evaluations of diagnostic and screening tests
Deeks, J. J. (2001) · BMJ · doi:10.1136/bmj.323.7305.157 · Cited by 1,340
Mucosal Healing in Inflammatory Bowel Disease: Results From a Norwegian Population-Based Cohort
Frøslie, K. F., Jahnsen, J., Moum, B. A., & Vatn, M. H. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.051 · Cited by 1,121
Conducting systematic reviews of diagnostic studies: didactic guidelines
Devillé, W. L., Buntinx, F., Bouter, L. M., Montori, V. M., de Vet, H. C., van der Windt, D. A., & Bezemer, P. D. (2002) · BMC Medical Research Methodology · doi:10.1186/1471-2288-2-9 · Cited by 960
Laboratory markers in IBD: useful, magic, or unnecessary toys?
Vermeire, S., Van Assche, G., & Rutgeerts, P. (2006) · Gut · doi:10.1136/gut.2005.069476 · Cited by 952
Systematic reviews of evaluations of diagnostic and screening tests
(2001) · Europe PMC (PubMed Central) · Cited by 850
Sources of Variation and Bias in Studies of Diagnostic Accuracy: A Systematic Review
Whiting, P., Rutjes, A. W. S., Reitsma, J. B., Glas, A. S., Bossuyt, P. M. M., & Kleijnen, J. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-3-200402030-00010 · Cited by 798
Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Weswood, M. E., Rutjes, A. W., Reitsma, J. B., Bossuyt, P. N., & Kleijnen, J. (2006) · BMC Medical Research Methodology · doi:10.1186/1471-2288-6-9 · Cited by 769
Tibble, J. A., Sigthorsson, G., Bridger, S., Fagerhol, M. K., & Bjarnason, I. (2000) · Gastroenterology · doi:10.1053/gast.2000.8523 · Cited by 759
van Rheenen, P. F., Van de Vijver, E., & Fidler, V. (2010) · BMJ · doi:10.1136/bmj.c3369 · Cited by 714
Assessment of the Neutrophil Dominating Protein Calprotectin in Feces: A Methodologic Study
RØseth, A. G., Fagerhol, M. K., Aadland, E., & Schjønsby, H. (1992) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529209011186 · Cited by 669
Microscopic activity in ulcerative colitis: what does it mean?
Riley, S. A., Mani, V, Goodman, M. J., Dutt, S., & Herd, M. E. (1991) · Gut · doi:10.1136/gut.32.2.174 · Cited by 564
Costa, F., Mumolo, M. G., Ceccarelli, L., Bellini, M., Romano, M. R., Sterpi, C., Ricchiuti, A., Marchi, S., & Bottai, M. (2005) · Gut · doi:10.1136/gut.2004.043406 · Cited by 550
Sipponen, T., Savilahti, E., Kolho, K.-L., Nuutinen, H., Turunen, U., & Färkkilä, M. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20312 · Cited by 480
Diagnostic Precision of Fecal Calprotectin for Inflammatory Bowel Disease and Colorectal Malignancy
von Roon, A. C., Karamountzos, L., Purkayastha, S., Reese, G. E., Darzi, A. W., Teare, J. P., Paraskeva, P., & Tekkis, P. P. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01126.x · Cited by 401
Røseth, A. G., Aadland, E., Jahnsen, J., & Raknerud, N. (1997) · Digestion · doi:10.1159/000201441 · Cited by 365
Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse
Gisbert, J. P., Bermejo, F., Pérez-Calle, J.-L., Taxonera, C., Vera, I., McNicholl, A. G., Algaba, A., López, P., López-Palacios, N., Calvo, M., et al. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20933 · Cited by 315
Gisbert, J. P., & McNicholl, A. G. (2009) · Digestive and Liver Disease · doi:10.1016/j.dld.2008.05.008 · Cited by 238
Can Calprotectin Predict Relapse Risk in Inflammatory Bowel Disease?
D'Incà, R., Dal Pont, E., Di Leo, V., Benazzato, L., Martinato, M., Lamboglia, F., Oliva, L., & Carlo Sturniolo, G. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01870.x · Cited by 211
Faecal calprotectin: a marker of inflammation throughout the intestinal tract
Aadland, E., & Fagerhol, M. K. (2002) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200208000-00002 · Cited by 207
Established and emerging biological activity markers of inflammatory bowel disease
Nielsen, O. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00849-7 · Cited by 195
Fecal Calprotectin Predicts the Clinical Course of Acute Severe Ulcerative Colitis
Ho, G. T., Lee, H. M., Brydon, G., Ting, T., Hare, N., Drummond, H., Shand, A. G., Bartolo, D. C., Wilson, R. G., Dunlop, M. G., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.119 · Cited by 171
Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?
García-Sánchez, V., Iglesias-Flores, E., González, R., Gisbert, J. P., Gallardo-Valverde, J. M., González-Galilea, Á., Naranjo-Rodríguez, A., de Dios-Vega, J. F., Muntané, J., & Gómez-Camacho, F. (2010) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2009.09.008 · Cited by 163
Wagner, M. S., Peterson, C. G. B., Ridefelt, P., Sangfelt, P., & Carlson, M. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.5584 · Cited by 149
Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease
Walkiewicz, D., Werlin, S. L., Fish, D. L., Scanlon, M. C., Hanaway, P. J., & Kugathasan, S. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20376 · Cited by 135
Kallel, L., Ayadi, I., Matri, S., Fekih, M., Mahmoud, N. B., Feki, M., Karoui, S., Zouari, B., Boubaker, J., Kaabachi, N., et al. (2010) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32832bab49 · Cited by 118
Faecal calprotectin in children with clinically quiescent inflammatory bowel disease
Sipponen, T. M., & Kolho, K. (2010) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521003782389 · Cited by 88
Diamanti, A., Colistro, F., Basso, M. S., Papadatou, B., Francalanci, P., Bracci, F., Muraca, M., Knafelz, D., Angelis, P. D., & Castro, M. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20472 · Cited by 74
Clinical Remission in Crohn’s Disease – Assessment Using Faecal 111 ln Granulocyte Excretion
Saverymuttu, S. H. (2009) · Digestion · doi:10.1159/000199277 · Cited by 59
Papel de los marcadores biológicos en la enfermedad inflamatoria intestinal
Gisbert, J. P., González‐Lama, Y., & Maté, J. (2007) · Gastroenterología y Hepatología · doi:10.1157/13100073 · Cited by 45
Inflammatory biomarkers predict relapse in IBD
Hanaway, P. J., & Roseth, A. (2005) · Gut · doi:10.1136/gut.2005.070615 · Cited by 11
Cited by
Maaser, C., Sturm, A., Vavricka, S. R., Kucharzik, T., Fiorino, G., Annese, V., Calabrese, E., Baumgart, D. C., Bettenworth, D., Borralho Nunes, P., et al. (2019) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjy113 · Cited by 1,823
Roda, G., Chien Ng, S., Kotze, P. G., Argollo, M., Panaccione, R., Spinelli, A., Kaser, A., Peyrin-Biroulet, L., & Danese, S. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0156-2 · Cited by 1,023
Calprotectin: from biomarker to biological function
Jukic, A., Bakiri, L., Wagner, E. F., Tilg, H., & Adolph, T. E. (2021) · Gut · doi:10.1136/gutjnl-2021-324855 · Cited by 500
Environmental enteropathy: critical implications of a poorly understood condition
Korpe, P. S., & Petri, W. A. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.04.007 · Cited by 449
van Enst, W. A., Ochodo, E., Scholten, R. J., Hooft, L., & Leeflang, M. M. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-70 · Cited by 429
Metadata
- Authors
- Mao, R., Xiao, Y.-L., Gao, X., Chen, B.-L., He, Y., Yang, L., Hu, P.-J., & Chen, M.-H.
- Venue
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-10
- Volume
- 18
- Issue
- 10
- Pages
- 1894-1899
- ISSN
- 1078-0998 (ISSN-L)
- OpenAlex
- W1990311132
- Cited by
- 280
- References
- 31
- FWCI
- 2.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.